Relapse of Inflammatory Bowel Disease Associated With Use of Nonsteroidal Anti-Inflammatory Drugs
- 222 Downloads
To determine whether an association exists between relapse in inflammatory bowel disease and use of nonsteroidal anti-inflammatory drugs (NSAIDs), a retrospective records review was conducted of patients with Crohn's disease, ulcerative colitis, or indeterminate colitis examined at an outpatient tertiary care center between July 17, 2000, and November 1, 2001. Extracted data collected during the patient's last visit included medication use, maintenance therapy, disease activity, and smoking status. Use of NSAIDs was defined as a daily dose or more of any type the month before relapse. Of 60 patients (22, relapse; 38, remission), 9 (41%) in relapse and 10 (26%) in remission used NSAIDs. Maintenance therapy varied from 68% (relapse) to 92% (remission). The adjusted odds ratio between medication use and relapse was 6.31 (95% confidence interval, 1.16–34.38; P = .03). Use of NSAIDs was associated with relapse. A prospective cohort study that corrects for maintenance therapy is needed to evaluate this relationship.
Key WordsCrohn's disease colitis ulcerative inflammatory bowel disease nonsteroidal anti-inflammatory drugs
Unable to display preview. Download preview PDF.
- 2.2 Rodger IW, Chan C-C: Inducible cyclooxygenase (COX-2): A target for novel anti-inflammatory drugs. In Neuroinflammation, Mechanisms and Management. Wood PL, (ed). Totowa, NJ, Humana Press, 1998, pp 355–373Google Scholar
- 9.9 Pearson DJ, Stones NA, Bentley SJ: Proctocolitis induced by salicylate and associated with asthma and recurrent nasal polyps. Br Med J (Clin Res Ed) 287:1675, 1983Google Scholar
- 10.10 Walt RP, Hawkey CJ, Langman MJ: Colitis associated with non-steroidal anti-inflammatory drugs (letter). Br Med J (Clin Res Ed) 288:238, 1984Google Scholar
- 11.11 Rutherford D, Stockdill G, Hamer-Hodges DW, Ferguson A: Proctolitis induced by salicylate. Br Med J (Clin Res Ed) 288:794, 1984Google Scholar
- 14.14 Smale S, Sigthorsson G, Foster R, Forgacs I, Bjarnason I: NSAIDs and relapse of IBD (abstract). Gastroenterology 122(Suppl 1):A23, 2002Google Scholar
- 16.16 Dominitz JA, Koepsell TD, Boyko EJ: Association between analgesic use and inflammatory bowel disease (IBD) flares: A retrospective cohort study (abstract). Gastroenterology 118(Suppl 2):A581, 2000Google Scholar
- 17.17 Bonner GF, Vennamaneni S: Use of nonsteroidal anti-inflammatory drugs in outpatients with inflammatory bowel disease (abstract). Gastroenterology 2001;120(Suppl 1):A269, 2001Google Scholar
- 29.29 Karmeli F, Cohen P, Rachmilewitz D: Cyclo-oxygenase-2 inhibitors ameliorate the severity of experimental colitis in rats. Eur J Gastroentrol Hepatol 12:223–231, 2000Google Scholar
- 38.38 Reinisch W, Miehsler WP, Dejaco C, Glauninger P, Vogelsang H: Treatment of peripheral arthropathy in IBD with rofecoxib, a selective COX-2 inhibitor (abstract). Gastroenterology 120(Suppl 1):A277, 2001Google Scholar
- 40.40 Tierney LM, McPhee SJ, Papdakis MA: Current Medical Diagnosis and Treatment 2001, 40th ed. New York, Lange Medical Books/McGraw Hill, 2001, pp 641–645Google Scholar